Skip to main content

Specimen Collection Manual and Test Catalog

  or
  or
  or

THROMBOSIS PROFILE

Geisinger Epic Procedure Code:  LAB3154    Geisinger Epic ID:  26811

SPECIMEN COLLECTION
Specimen type: 

Platelet-poor plasma AND serum.


Alternate collection container: 
6 mL red-top (plain, non-serum separator) tube
Other size blue-top (3.2% sodium citrate) tubes (e.g., 1.8 mL, 4.5 mL)
Specimen required: 

Eight (8) 1 mL plasma aliquots AND (1) 0.5 mL serum 
Collect four (4) 2.7 mL blue-top tubes (3.2% sodium citrate) AND one (1) 3.5 mL gold-top (serum separator) tube.


Special notes: 
  • If the patient’s hematocrit (HCT) is >55%, the volume of anticoagulant in the tube should be adjusted. Contact a performing location for special tube preparation to reduce the citrate in the collection tube. For those patients with HCT >65.4% see LAB3632 Stago Sodium Citrate Adjustment Chart for formula to determine amount of citrate removal required.
  • When possible, use fresh venipuncture to collect blood to avoid activation of coagulation by tissue thromboplastin. Blood may be drawn from an indwelling catheter or vascular access device. Draw sample from a lumen that has not been heparinized or flush the line with 5 ml of saline, and discard the first 10 mL of blood.
  • Tubes should be >90% filled.
  • Immediately mix gently after collection by inverting the tube end over end 5 to 6 times. Avoid vigorous mixing or additional inversion. Observe for the presence of clots. Recollect if fibrin clots observed.
  • Transport at ambient temperature to processing location and processing should be completed within 4 hours.
  • Butterfly device collections, draw a discard tube first to remove air from collection tubing.

Patient preparation: 

Thrombosis testing immediately after a thrombotic event is discouraged. Patient should be off all anticoagulation prior to collection as follows:
Heparin- 48 hours 
Coumadin - 2 weeks 
Direct thrombin or Xa inhibitors - 7 days
Anti-platelet medication- no need to stop



SPECIMEN PROCESSING
Processing instructions: 

Centrifuge blue top specimens immediately at designated time and speed to obtain platelet-poor plasma (<10,000/µL). Using a plastic pipette, carefully remove plasma from cells, avoiding platelet/buffy layer by leaving a thin layer of plasma on top the cells. The centrifuged plasma should be aliquoted (1 mL per aliquot) into clearly labeled polypropylene tubes. Eight (8) plasma aliquots needed. Check the residual specimen for clot and if present discard sample and redraw specimen. Freeze upright and transport on dry ice.

Allow serum to clot. Centrifuge and submit 0.5 mL serum.


Transport temperature: 

Eight (8) aliquots of citrated plasma frozen, one (1) aliquot of serum refrigerated


Specimen stability: 

Plasma room temperature: 4 hours
Plasma frozen -20°C: 2 weeks
Plasma frozen -70°C: 6 months

Serum room temperature: 8 hours
Serum refrigerated 2-8°C: 48 hours
Serum frozen: 6 months


Rejection criteria: 

Clotted, hemolyzed, icteric (test specific), lipemic (test specific) improperly filled tubes, improper anticoagulant ratio (HCT >55% and citrate not adjusted), refrigerated specimens, or stability exceeded.

Note: Specimen suspected of thawing in transport, indicated by slant in aliquot or specimen in lid of tube, will have testing performed, and the comment “interpret results with caution as thawing suspected” added to results.



TEST DETAILS
Reference interval: 

See individual tests.


CPT code(s):  85613, 85730, 86147 x2, 86146 x2, 85300, 85306, 85384, 85303, If reflex testing needed the following may be added depending on lupus profile algorithm and protein S activity reflex panel: 85613 x2, 85730, 85525 x7, 85610, 85597, 85670 x2, 85520, 85384, 88732, 85597, 85306, 85305
Note: The billing party has sole responsibility for CPT coding.  Any questions regarding coding should be directed to the payer being billed.
The CPT codes provided by GML are based on AMA guidelines and are for informational purposes only.

Test includes: 

Antithrombin III Activity, Protein C Activity, Protein S Activity with reflex to Free and Total Protein S Antigen, Lupus Sensitive APTT with reflex heparin neutralization, Mixing, and platelet neutralization confirmation; DRVVT with reflexive heparin neutralization, Mixing, and Confirmation; IgG and IgM Anticardiolipin antibodies, IgG and IgM Beta-2-Glycoprotein antibodies, if required by algorithm fibrinogen, Heparin Unfractionated and/or Thrombin Time with and without heparin neutralization if indicated.

Profile does NOT include Factor V (5) Leiden or Prothrombin gene mutation testing.

Lupus Anticoagulant Profile Workflow


Methodology: 
Chromogenic
Clauss
Enzyme Immunoassay (EIA)
Immunoturbidometric
Mechanical clot-based
Synonyms: 

THRMP, Hypercoagulation panel, Hypercoagulability, Thrombophilic, thrombotic, lupus anticoagulant


Clinical significance: 

Thrombosis profile evaluates for inherited and acquired thrombophilia risk factors in patients with a clotting event and/or a strong family history of unprovoked blood clot. Results should be combined with clinical history and clinical risk factors to determine the need for extended anticoagulation. Thrombotic testing immediately after a thrombotic event is discouraged. Anticoagulant therapy and ongoing or recent thrombotic events interfere with interpreation of some results, especially lupus anticoagulant profile testing. If anticoagulation is detected the lupus profile will be resulted with a comment stating anticoagulation detect and indeterminant for lupus anticoagulant. See Anticoagulation Impact on Coagulation Tests for effects on other analytes.


Doctoral Director(s): 
Michelle Grant DO
Review Date:  03/05/2025

Performing Locations